Sage Journals: Discover world-class research

Abstract

Background:

Evidence-based complementary treatment options for multiple sclerosis (MS) are limited.

Objective:

To investigate the effect of hippotherapy plus standard care versus standard care alone in MS patients.

Methods:

A total of 70 adults with MS were recruited in five German centers and randomly allocated to the intervention group (12 weeks of hippotherapy) or the control group. Primary outcome was the change in the Berg Balance Scale (BBS) after 12 weeks, and further outcome measures included fatigue, pain, quality of life, and spasticity.

Results:

Covariance analysis of the primary endpoint resulted in a mean difference in BBS change of 2.33 (95% confidence interval (CI): 0.03–4.63, p = 0.047) between intervention (n = 32) and control (n = 38) groups. Benefit on BBS was largest for the subgroup with an Expanded Disability Status Scale (EDSS) ⩾ 5 (5.1, p = 0.001). Fatigue (−6.8, p = 0.02) and spasticity (−0.9, p = 0.03) improved in the intervention group. The mean difference in change between groups was 12.0 (p < 0.001) in physical health score and 14.4 (p < 0.001) in mental health score of Multiple Sclerosis Quality of Life-54 (MSQoL-54).

Conclusion:

Hippotherapy plus standard care, while below the threshold of a minimal clinically important difference, significantly improved balance and also fatigue, spasticity, and quality of life in MS patients.

Keywords

Berg balance scale hippotherapy equine-assisted therapy multiple sclerosis spasticity quality of life

Get full access to this article

View all access options for this article.

References

Strauß

Hippotherapie: Physiotherapie mit und auf dem Pferd. Stuttgart: Georg Thieme Verlag KG, 2008.

Wuethrich

Kuenzle

Hippotherapy in multiple sclerosis (author’s transl). J Belge Med Phys Rehabil 1978; 1(3): 265–268.

Frevel

Mäurer

Internet-based home training is capable to improve balance in multiple sclerosis: A randomized controlled trial. Eur J Phys Rehabil Med 2015; 51(1): 23–30.

Schneider

Puta

Drache

. Auswirkungen der Hippotherapie auf den Krankheitsverlauf der Multiplen Sklerose. Pilotstudie zur Erfassung der Auswirkungen auf Spastik, dynamisches/statisches Gleichgewicht, Fatigue, Lebensqualität und Schmerzempfinden, http://johannisberg.net/app/download/5780747719/Abstract+zweite+MS+Studie.pdf (accessed October 2010).

Sager

Schaar

Drache

et al . Hippotherapie bei Multipler Sklerose—Pilotstudie zur Erfassungen der Auswirkungen auf Gleichgewicht, Spastik, Gehfähigkeit und Lebensqualität, 2007, http://johannisberg.net/app/download/5780747694/Abstract+erste+MS+Studie.pdf (accessed March 2008).

Wollenweber

Drache

Schickendantz

et al . Study of the effectiveness of hippotherapy on the symptoms of multiple sclerosis—Outline of a randomised controlled multicentre study (MS-HIPPO). Contemp Clin Trials Commun 2016; 3: 6–11.

Moher

Hopewell

Schulz

et al . CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trials. BMJ 2010; 340: c869.

Deutsches Kuratorium für Therapeutisches Reiten e.V. Durchführungsbestimmungen (Richtlinien) für die Hippotherapie (DKThR), https://www.dkthr.de/fileadmin/redaktion/downloads/Durchführungsbestimmungen_in_den_vier_Fachbereichen_des_Therapeutischen_Reitens__Stand_30.05.2016.pdf (accessed 28 May 2013).

Kurtzke

JF.

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 1983; 33(11): 1444–1452.

10.

Schädler

Ein aufschlussreicher Test fürs Gleichgewicht. Assessment: Berg Balance Scale. Physiopraxis 2007; 5(11–12): 40–41.

11.

Berg

Wood-Dauphinee

Williams

et al . Measuring balance in the elderly: Preliminary development of an instrument. Physiother Can 1989; 41(6): 304–311.

12.

Berg

Wood-Dauphinee

Williams

et al . Measuring balance in the elderly: Validation of an instrument. Can J Public Health 1992; 83(suppl. 2): S7–S11.

13.

Berg

Wood-Dauphinee

Williams

JI.

The Balance Scale: Reliability assessment with elderly residents and patients with an acute stroke. Scand J Rehabil Med 1995; 27(1): 27–36.

14.

Krupp

LaRocca

Muir-Nash

et al . The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989; 46(10): 1121–1123.

15.

Pfeffer

Einsatz bei Erschöpfung. Assessment: Fatigue Severity Scale. Physiopraxis 2008; 6(10): 42–43.

16.

Vickrey

Hays

Harooni

et al . A health-related quality of life measure for multiple sclerosis. Qual Life Res 1995; 4(3): 187–206.

17.

Carlsson

. Assessment of chronic pain. I. Aspects of the reliability and validity of the visual analogue scale. Pain 1983; 16(1): 87–101.

18.

Grau-Lopez

Sierra

Martinez-Caceres

et al . Analysis of the pain in multiple sclerosis patients. Neurologia 2011; 26(4): 208–213.

19.

Bhimani

Anderson

Henly

et al . Clinical measurement of limb spasticity in adults: State of the science. J Neurosci Nurs 2011; 43(2): 104–115.

20.

Stevenson

TJ.

Detecting change in patients with stroke using the Berg Balance Scale. Aust J Physiother 2001; 47(1): 29–38.

21.

Downs

Marquez

Chiarelli

The Berg Balance Scale has high intra- and inter-rater reliability but absolute reliability varies across the scale: A systematic review. J Physiother 2013; 59(2): 93–99.

22.

Beauchamp

Harrison

Goldstein

et al . Interpretability of change scores in measures of balance in people with COPD. Chest 2016; 149(3): 696–703.

23.

Lord

Wade

Halligan

PW.

A comparison of two physiotherapy treatment approaches to improve walking in multiple sclerosis: A pilot randomized controlled study. Clin Rehabil 1998; 12(6): 477–486.

24.

Henze

Rieckmann

Toyka

; Multiple Sclerosis Therapy Consensus Group of the German Multiple Sclerosis Society. Symptomatic treatment of multiple sclerosis. Multiple Sclerosis Therapy Consensus Group (MSTCG) of the German Multiple Sclerosis Society. Eur Neurol 2006; 56(2): 78–105.

25.

Stuke

Flachenecker

Zettl

et al . Symptomatology of MS: Results from the German MS Registry. J Neurol 2009; 256(11): 1932–1935.

26.

Toosy

Ciccarelli

Thompson

Symptomatic treatment and management of multiple sclerosis. Handb Clin Neurol 2014; 122: 513–562.

27.

Taheri

Negahban

Mostafaee

et al . Responsiveness of selected outcome measures of participation restriction and quality of life in patients with multiple sclerosis. Disabil Rehabil 2016; 38(5): 482–486.

28.

Heine

van

Port

Rietberg

et al . Exercise therapy for fatigue in multiple sclerosis. Cochrane Database Syst Rev 2015; 9: CD009956.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.14 MB

0.38 MB

0.50 MB

0.13 MB

Hippotherapy for patients with multiple sclerosis: A multicenter randomized controlled trial (MS-HIPPO)

Abstract

Background:

Objective:

Methods:

Results:

Conclusion:

Keywords

Get full access to this article

References

Supplementary Material